Aim: The aim of this multicenter retrospective study was to explore associations between antifibrotic therapy and (i) OS after cancer diagnosis and (ii) post-treatment AE-ILD in patients with fibrotic ILD who develop lung cancer, and to provide hypothesis-generating observations regarding PD-L1 and autoimmune features. This evidence concerns the gene CD274 and interstitial lung disease.